Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
33,560
archived clinical trials in
Neurology

Open-label, Pharmacokinetic, Safety and Efficacy Study of Adjunctive Brivaracetam in Children With Epilepsy.
Open-Label, Single-Arm, Multicenter, Pharmacokinetic, Safety, and Efficacy Study of Adjunctive Administration of Brivaracetam in Subjects From ≥1 Month to <16 Years Old With Epilepsy
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1703
mi
from 98109
Chesterfield, MO
Open-label, Pharmacokinetic, Safety and Efficacy Study of Adjunctive Brivaracetam in Children With Epilepsy.
Open-Label, Single-Arm, Multicenter, Pharmacokinetic, Safety, and Efficacy Study of Adjunctive Administration of Brivaracetam in Subjects From ≥1 Month to <16 Years Old With Epilepsy
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1703
mi
from 98109
Chesterfield, MO
Click here to add this to my saved trials
Open-label, Pharmacokinetic, Safety and Efficacy Study of Adjunctive Brivaracetam in Children With Epilepsy.
Open-Label, Single-Arm, Multicenter, Pharmacokinetic, Safety, and Efficacy Study of Adjunctive Administration of Brivaracetam in Subjects From ≥1 Month to <16 Years Old With Epilepsy
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2110
mi
from 98109
Buffalo, NY
Open-label, Pharmacokinetic, Safety and Efficacy Study of Adjunctive Brivaracetam in Children With Epilepsy.
Open-Label, Single-Arm, Multicenter, Pharmacokinetic, Safety, and Efficacy Study of Adjunctive Administration of Brivaracetam in Subjects From ≥1 Month to <16 Years Old With Epilepsy
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2110
mi
from 98109
Buffalo, NY
Click here to add this to my saved trials
Open-label, Pharmacokinetic, Safety and Efficacy Study of Adjunctive Brivaracetam in Children With Epilepsy.
Open-Label, Single-Arm, Multicenter, Pharmacokinetic, Safety, and Efficacy Study of Adjunctive Administration of Brivaracetam in Subjects From ≥1 Month to <16 Years Old With Epilepsy
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2161
mi
from 98109
Rochester, NY
Open-label, Pharmacokinetic, Safety and Efficacy Study of Adjunctive Brivaracetam in Children With Epilepsy.
Open-Label, Single-Arm, Multicenter, Pharmacokinetic, Safety, and Efficacy Study of Adjunctive Administration of Brivaracetam in Subjects From ≥1 Month to <16 Years Old With Epilepsy
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2161
mi
from 98109
Rochester, NY
Click here to add this to my saved trials
Open-label, Pharmacokinetic, Safety and Efficacy Study of Adjunctive Brivaracetam in Children With Epilepsy.
Open-Label, Single-Arm, Multicenter, Pharmacokinetic, Safety, and Efficacy Study of Adjunctive Administration of Brivaracetam in Subjects From ≥1 Month to <16 Years Old With Epilepsy
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1967
mi
from 98109
Cincinnati, OH
Open-label, Pharmacokinetic, Safety and Efficacy Study of Adjunctive Brivaracetam in Children With Epilepsy.
Open-Label, Single-Arm, Multicenter, Pharmacokinetic, Safety, and Efficacy Study of Adjunctive Administration of Brivaracetam in Subjects From ≥1 Month to <16 Years Old With Epilepsy
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1967
mi
from 98109
Cincinnati, OH
Click here to add this to my saved trials
Open-label, Pharmacokinetic, Safety and Efficacy Study of Adjunctive Brivaracetam in Children With Epilepsy.
Open-Label, Single-Arm, Multicenter, Pharmacokinetic, Safety, and Efficacy Study of Adjunctive Administration of Brivaracetam in Subjects From ≥1 Month to <16 Years Old With Epilepsy
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2132
mi
from 98109
Pittsburgh, PA
Open-label, Pharmacokinetic, Safety and Efficacy Study of Adjunctive Brivaracetam in Children With Epilepsy.
Open-Label, Single-Arm, Multicenter, Pharmacokinetic, Safety, and Efficacy Study of Adjunctive Administration of Brivaracetam in Subjects From ≥1 Month to <16 Years Old With Epilepsy
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2132
mi
from 98109
Pittsburgh, PA
Click here to add this to my saved trials
Open-label, Pharmacokinetic, Safety and Efficacy Study of Adjunctive Brivaracetam in Children With Epilepsy.
Open-Label, Single-Arm, Multicenter, Pharmacokinetic, Safety, and Efficacy Study of Adjunctive Administration of Brivaracetam in Subjects From ≥1 Month to <16 Years Old With Epilepsy
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1970
mi
from 98109
Nashville, TN
Open-label, Pharmacokinetic, Safety and Efficacy Study of Adjunctive Brivaracetam in Children With Epilepsy.
Open-Label, Single-Arm, Multicenter, Pharmacokinetic, Safety, and Efficacy Study of Adjunctive Administration of Brivaracetam in Subjects From ≥1 Month to <16 Years Old With Epilepsy
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1970
mi
from 98109
Nashville, TN
Click here to add this to my saved trials
Open-label, Pharmacokinetic, Safety and Efficacy Study of Adjunctive Brivaracetam in Children With Epilepsy.
Open-Label, Single-Arm, Multicenter, Pharmacokinetic, Safety, and Efficacy Study of Adjunctive Administration of Brivaracetam in Subjects From ≥1 Month to <16 Years Old With Epilepsy
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2730
mi
from 98109
Miami, FL
Open-label, Pharmacokinetic, Safety and Efficacy Study of Adjunctive Brivaracetam in Children With Epilepsy.
Open-Label, Single-Arm, Multicenter, Pharmacokinetic, Safety, and Efficacy Study of Adjunctive Administration of Brivaracetam in Subjects From ≥1 Month to <16 Years Old With Epilepsy
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2730
mi
from 98109
Miami, FL
Click here to add this to my saved trials
Open-label, Pharmacokinetic, Safety and Efficacy Study of Adjunctive Brivaracetam in Children With Epilepsy.
Open-Label, Single-Arm, Multicenter, Pharmacokinetic, Safety, and Efficacy Study of Adjunctive Administration of Brivaracetam in Subjects From ≥1 Month to <16 Years Old With Epilepsy
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1890
mi
from 98109
Houston, TX
Open-label, Pharmacokinetic, Safety and Efficacy Study of Adjunctive Brivaracetam in Children With Epilepsy.
Open-Label, Single-Arm, Multicenter, Pharmacokinetic, Safety, and Efficacy Study of Adjunctive Administration of Brivaracetam in Subjects From ≥1 Month to <16 Years Old With Epilepsy
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1890
mi
from 98109
Houston, TX
Click here to add this to my saved trials
Open-label, Pharmacokinetic, Safety and Efficacy Study of Adjunctive Brivaracetam in Children With Epilepsy.
Open-Label, Single-Arm, Multicenter, Pharmacokinetic, Safety, and Efficacy Study of Adjunctive Administration of Brivaracetam in Subjects From ≥1 Month to <16 Years Old With Epilepsy
Status: Enrolling
Updated:  12/31/1969
Investigational Site
4933
mi
from 98109
Brussels,
Open-label, Pharmacokinetic, Safety and Efficacy Study of Adjunctive Brivaracetam in Children With Epilepsy.
Open-Label, Single-Arm, Multicenter, Pharmacokinetic, Safety, and Efficacy Study of Adjunctive Administration of Brivaracetam in Subjects From ≥1 Month to <16 Years Old With Epilepsy
Status: Enrolling
Updated: 12/31/1969
Investigational Site
4933
mi
from 98109
Brussels,
Click here to add this to my saved trials
Open-label, Pharmacokinetic, Safety and Efficacy Study of Adjunctive Brivaracetam in Children With Epilepsy.
Open-Label, Single-Arm, Multicenter, Pharmacokinetic, Safety, and Efficacy Study of Adjunctive Administration of Brivaracetam in Subjects From ≥1 Month to <16 Years Old With Epilepsy
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1400
mi
from 98109
Saint Paul, MN
Open-label, Pharmacokinetic, Safety and Efficacy Study of Adjunctive Brivaracetam in Children With Epilepsy.
Open-Label, Single-Arm, Multicenter, Pharmacokinetic, Safety, and Efficacy Study of Adjunctive Administration of Brivaracetam in Subjects From ≥1 Month to <16 Years Old With Epilepsy
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1400
mi
from 98109
Saint Paul, MN
Click here to add this to my saved trials
Hematopoietic Stem Cell Therapy for Patients With Refractory Myasthenia Gravis
Hematopoietic Stem Cell Therapy for Patients With Refractory Myasthenia Gravis
Status: Enrolling
Updated:  12/31/1969
Northwestern University Feinberg School of Medicine
1732
mi
from 98109
Chicago, IL
Hematopoietic Stem Cell Therapy for Patients With Refractory Myasthenia Gravis
Hematopoietic Stem Cell Therapy for Patients With Refractory Myasthenia Gravis
Status: Enrolling
Updated: 12/31/1969
Northwestern University Feinberg School of Medicine
1732
mi
from 98109
Chicago, IL
Click here to add this to my saved trials
Brain Peripheral Benzodiazepine Receptors in Patients With Multiple Sclerosis
PET Evaluation of Brain Peripheral Benzodiazepine Receptors Using [(11)C]PBR28 in Patients With Multiple Sclerosis (MS)
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
2315
mi
from 98109
Bethesda, MD
Brain Peripheral Benzodiazepine Receptors in Patients With Multiple Sclerosis
PET Evaluation of Brain Peripheral Benzodiazepine Receptors Using [(11)C]PBR28 in Patients With Multiple Sclerosis (MS)
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
2315
mi
from 98109
Bethesda, MD
Click here to add this to my saved trials
Methylphenidate (Ritalin) and Memory/Attention in Traumatic Brain Injury (TBI)
Methylphenidate (Ritalin) and Memory/Attention in Traumatic Brain Injury (TBI)
Status: Enrolling
Updated:  12/31/1969
University of Colorado at Denver
1020
mi
from 98109
Denver, CO
Methylphenidate (Ritalin) and Memory/Attention in Traumatic Brain Injury (TBI)
Methylphenidate (Ritalin) and Memory/Attention in Traumatic Brain Injury (TBI)
Status: Enrolling
Updated: 12/31/1969
University of Colorado at Denver
1020
mi
from 98109
Denver, CO
Click here to add this to my saved trials
Methylphenidate (Ritalin) and Memory/Attention in Traumatic Brain Injury (TBI)
Methylphenidate (Ritalin) and Memory/Attention in Traumatic Brain Injury (TBI)
Status: Enrolling
Updated:  12/31/1969
Indiana University
1866
mi
from 98109
Indianapolis, IN
Methylphenidate (Ritalin) and Memory/Attention in Traumatic Brain Injury (TBI)
Methylphenidate (Ritalin) and Memory/Attention in Traumatic Brain Injury (TBI)
Status: Enrolling
Updated: 12/31/1969
Indiana University
1866
mi
from 98109
Indianapolis, IN
Click here to add this to my saved trials
Methylphenidate (Ritalin) and Memory/Attention in Traumatic Brain Injury (TBI)
Methylphenidate (Ritalin) and Memory/Attention in Traumatic Brain Injury (TBI)
Status: Enrolling
Updated:  12/31/1969
Dartmouth Hitchcock Medical Center
2392
mi
from 98109
Lebanon, NH
Methylphenidate (Ritalin) and Memory/Attention in Traumatic Brain Injury (TBI)
Methylphenidate (Ritalin) and Memory/Attention in Traumatic Brain Injury (TBI)
Status: Enrolling
Updated: 12/31/1969
Dartmouth Hitchcock Medical Center
2392
mi
from 98109
Lebanon, NH
Click here to add this to my saved trials
Aricept to Improve Functional Tasks in Vascular Dementia
Phase 1 Study of Aricept Plus a Behavioral Strategy to Improve Functional Tasks in Vascular Dementia
Status: Enrolling
Updated:  12/31/1969
Kessler Foundation
mi
from 98109
West Orange, NJ
Aricept to Improve Functional Tasks in Vascular Dementia
Phase 1 Study of Aricept Plus a Behavioral Strategy to Improve Functional Tasks in Vascular Dementia
Status: Enrolling
Updated: 12/31/1969
Kessler Foundation
mi
from 98109
West Orange, NJ
Click here to add this to my saved trials
PET Evaluation of Brain Peripheral Benzodiazepine Receptors Using [11C]PBR28 in HIV-Seropositive Patients With (MCMD)
PET Evaluation of Brain Peripheral Benzodiazepine Receptors Using (11C)PBR28 in HIV-Seropositive Patients With (MCMD)
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
2315
mi
from 98109
Bethesda, MD
PET Evaluation of Brain Peripheral Benzodiazepine Receptors Using [11C]PBR28 in HIV-Seropositive Patients With (MCMD)
PET Evaluation of Brain Peripheral Benzodiazepine Receptors Using (11C)PBR28 in HIV-Seropositive Patients With (MCMD)
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
2315
mi
from 98109
Bethesda, MD
Click here to add this to my saved trials
Trial of Dasatinib in Advanced Sarcomas
A Phase II Trial of Dasatinib in Advanced Sarcomas
Status: Enrolling
Updated:  12/31/1969
Arkansas Children's Hospital
1782
mi
from 98109
Little Rock, AR
Trial of Dasatinib in Advanced Sarcomas
A Phase II Trial of Dasatinib in Advanced Sarcomas
Status: Enrolling
Updated: 12/31/1969
Arkansas Children's Hospital
1782
mi
from 98109
Little Rock, AR
Click here to add this to my saved trials
Trial of Dasatinib in Advanced Sarcomas
A Phase II Trial of Dasatinib in Advanced Sarcomas
Status: Enrolling
Updated:  12/31/1969
City of Hope
959
mi
from 98109
Duarte, CA
Trial of Dasatinib in Advanced Sarcomas
A Phase II Trial of Dasatinib in Advanced Sarcomas
Status: Enrolling
Updated: 12/31/1969
City of Hope
959
mi
from 98109
Duarte, CA
Click here to add this to my saved trials
Trial of Dasatinib in Advanced Sarcomas
A Phase II Trial of Dasatinib in Advanced Sarcomas
Status: Enrolling
Updated:  12/31/1969
Cedars-Sinai Outpatient Cancer Center
959
mi
from 98109
Los Angeles, CA
Trial of Dasatinib in Advanced Sarcomas
A Phase II Trial of Dasatinib in Advanced Sarcomas
Status: Enrolling
Updated: 12/31/1969
Cedars-Sinai Outpatient Cancer Center
959
mi
from 98109
Los Angeles, CA
Click here to add this to my saved trials
Trial of Dasatinib in Advanced Sarcomas
A Phase II Trial of Dasatinib in Advanced Sarcomas
Status: Enrolling
Updated:  12/31/1969
Stanford University
704
mi
from 98109
Palo Alto, CA
Trial of Dasatinib in Advanced Sarcomas
A Phase II Trial of Dasatinib in Advanced Sarcomas
Status: Enrolling
Updated: 12/31/1969
Stanford University
704
mi
from 98109
Palo Alto, CA
Click here to add this to my saved trials
Trial of Dasatinib in Advanced Sarcomas
A Phase II Trial of Dasatinib in Advanced Sarcomas
Status: Enrolling
Updated:  12/31/1969
Sarcoma Oncology Center
960
mi
from 98109
Santa Monica, CA
Trial of Dasatinib in Advanced Sarcomas
A Phase II Trial of Dasatinib in Advanced Sarcomas
Status: Enrolling
Updated: 12/31/1969
Sarcoma Oncology Center
960
mi
from 98109
Santa Monica, CA
Click here to add this to my saved trials
Trial of Dasatinib in Advanced Sarcomas
A Phase II Trial of Dasatinib in Advanced Sarcomas
Status: Enrolling
Updated:  12/31/1969
Washington Cancer Institute
2322
mi
from 98109
Washington,
Trial of Dasatinib in Advanced Sarcomas
A Phase II Trial of Dasatinib in Advanced Sarcomas
Status: Enrolling
Updated: 12/31/1969
Washington Cancer Institute
2322
mi
from 98109
Washington,
Click here to add this to my saved trials
Trial of Dasatinib in Advanced Sarcomas
A Phase II Trial of Dasatinib in Advanced Sarcomas
Status: Enrolling
Updated:  12/31/1969
Winship Cancer Institute at Emory University
2180
mi
from 98109
Atlanta, GA
Trial of Dasatinib in Advanced Sarcomas
A Phase II Trial of Dasatinib in Advanced Sarcomas
Status: Enrolling
Updated: 12/31/1969
Winship Cancer Institute at Emory University
2180
mi
from 98109
Atlanta, GA
Click here to add this to my saved trials
Trial of Dasatinib in Advanced Sarcomas
A Phase II Trial of Dasatinib in Advanced Sarcomas
Status: Enrolling
Updated:  12/31/1969
Kootenai Cancer Center
259
mi
from 98109
Coeur d'Alene, ID
Trial of Dasatinib in Advanced Sarcomas
A Phase II Trial of Dasatinib in Advanced Sarcomas
Status: Enrolling
Updated: 12/31/1969
Kootenai Cancer Center
259
mi
from 98109
Coeur d'Alene, ID
Click here to add this to my saved trials
Trial of Dasatinib in Advanced Sarcomas
A Phase II Trial of Dasatinib in Advanced Sarcomas
Status: Enrolling
Updated:  12/31/1969
Oncology Specialists
1719
mi
from 98109
Park Ridge, IL
Trial of Dasatinib in Advanced Sarcomas
A Phase II Trial of Dasatinib in Advanced Sarcomas
Status: Enrolling
Updated: 12/31/1969
Oncology Specialists
1719
mi
from 98109
Park Ridge, IL
Click here to add this to my saved trials
Trial of Dasatinib in Advanced Sarcomas
A Phase II Trial of Dasatinib in Advanced Sarcomas
Status: Enrolling
Updated:  12/31/1969
Indiana University Cancer Center
1867
mi
from 98109
Indianapolis, IN
Trial of Dasatinib in Advanced Sarcomas
A Phase II Trial of Dasatinib in Advanced Sarcomas
Status: Enrolling
Updated: 12/31/1969
Indiana University Cancer Center
1867
mi
from 98109
Indianapolis, IN
Click here to add this to my saved trials
Trial of Dasatinib in Advanced Sarcomas
A Phase II Trial of Dasatinib in Advanced Sarcomas
Status: Enrolling
Updated:  12/31/1969
University of Iowa Hospitals and Clinics
1557
mi
from 98109
Iowa City, IA
Trial of Dasatinib in Advanced Sarcomas
A Phase II Trial of Dasatinib in Advanced Sarcomas
Status: Enrolling
Updated: 12/31/1969
University of Iowa Hospitals and Clinics
1557
mi
from 98109
Iowa City, IA
Click here to add this to my saved trials
Trial of Dasatinib in Advanced Sarcomas
A Phase II Trial of Dasatinib in Advanced Sarcomas
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
2329
mi
from 98109
Baltimore, MD
Trial of Dasatinib in Advanced Sarcomas
A Phase II Trial of Dasatinib in Advanced Sarcomas
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
2329
mi
from 98109
Baltimore, MD
Click here to add this to my saved trials
Trial of Dasatinib in Advanced Sarcomas
A Phase II Trial of Dasatinib in Advanced Sarcomas
Status: Enrolling
Updated:  12/31/1969
Massachusetts General Hospital
2485
mi
from 98109
Boston, MA
Trial of Dasatinib in Advanced Sarcomas
A Phase II Trial of Dasatinib in Advanced Sarcomas
Status: Enrolling
Updated: 12/31/1969
Massachusetts General Hospital
2485
mi
from 98109
Boston, MA
Click here to add this to my saved trials
Trial of Dasatinib in Advanced Sarcomas
A Phase II Trial of Dasatinib in Advanced Sarcomas
Status: Enrolling
Updated:  12/31/1969
Dana-Farber Cancer Institute
2485
mi
from 98109
Boston, MA
Trial of Dasatinib in Advanced Sarcomas
A Phase II Trial of Dasatinib in Advanced Sarcomas
Status: Enrolling
Updated: 12/31/1969
Dana-Farber Cancer Institute
2485
mi
from 98109
Boston, MA
Click here to add this to my saved trials
Trial of Dasatinib in Advanced Sarcomas
A Phase II Trial of Dasatinib in Advanced Sarcomas
Status: Enrolling
Updated:  12/31/1969
University of Michigan
1903
mi
from 98109
Ann Arbor, MI
Trial of Dasatinib in Advanced Sarcomas
A Phase II Trial of Dasatinib in Advanced Sarcomas
Status: Enrolling
Updated: 12/31/1969
University of Michigan
1903
mi
from 98109
Ann Arbor, MI
Click here to add this to my saved trials
Trial of Dasatinib in Advanced Sarcomas
A Phase II Trial of Dasatinib in Advanced Sarcomas
Status: Enrolling
Updated:  12/31/1969
Nebraska Methodist Hospital
1361
mi
from 98109
Omaha, NE
Trial of Dasatinib in Advanced Sarcomas
A Phase II Trial of Dasatinib in Advanced Sarcomas
Status: Enrolling
Updated: 12/31/1969
Nebraska Methodist Hospital
1361
mi
from 98109
Omaha, NE
Click here to add this to my saved trials
Trial of Dasatinib in Advanced Sarcomas
A Phase II Trial of Dasatinib in Advanced Sarcomas
Status: Enrolling
Updated:  12/31/1969
Pennsylvania Oncology Hematology Associates
2374
mi
from 98109
Philadelphia, PA
Trial of Dasatinib in Advanced Sarcomas
A Phase II Trial of Dasatinib in Advanced Sarcomas
Status: Enrolling
Updated: 12/31/1969
Pennsylvania Oncology Hematology Associates
2374
mi
from 98109
Philadelphia, PA
Click here to add this to my saved trials
Trial of Dasatinib in Advanced Sarcomas
A Phase II Trial of Dasatinib in Advanced Sarcomas
Status: Enrolling
Updated:  12/31/1969
Fox Chase Cancer Center
2373
mi
from 98109
Philadelphia, PA
Trial of Dasatinib in Advanced Sarcomas
A Phase II Trial of Dasatinib in Advanced Sarcomas
Status: Enrolling
Updated: 12/31/1969
Fox Chase Cancer Center
2373
mi
from 98109
Philadelphia, PA
Click here to add this to my saved trials
Trial of Dasatinib in Advanced Sarcomas
A Phase II Trial of Dasatinib in Advanced Sarcomas
Status: Enrolling
Updated:  12/31/1969
University of Pittsburgh Cancer Institute
2135
mi
from 98109
Pittsburgh, PA
Trial of Dasatinib in Advanced Sarcomas
A Phase II Trial of Dasatinib in Advanced Sarcomas
Status: Enrolling
Updated: 12/31/1969
University of Pittsburgh Cancer Institute
2135
mi
from 98109
Pittsburgh, PA
Click here to add this to my saved trials
Trial of Dasatinib in Advanced Sarcomas
A Phase II Trial of Dasatinib in Advanced Sarcomas
Status: Enrolling
Updated:  12/31/1969
MD Anderson
1892
mi
from 98109
Houston, TX
Trial of Dasatinib in Advanced Sarcomas
A Phase II Trial of Dasatinib in Advanced Sarcomas
Status: Enrolling
Updated: 12/31/1969
MD Anderson
1892
mi
from 98109
Houston, TX
Click here to add this to my saved trials
Patent Foramen Ovale Closure or Medical Therapy After Stroke - RESPECT Trial
Randomized Evaluation of Recurrent Stroke Comparing PFO Closure to Established Current Standard of Care Treatment (RESPECT)
Status: Enrolling
Updated:  12/31/1969
University of Alabama
2079
mi
from 98109
Birmingham, AL
Patent Foramen Ovale Closure or Medical Therapy After Stroke - RESPECT Trial
Randomized Evaluation of Recurrent Stroke Comparing PFO Closure to Established Current Standard of Care Treatment (RESPECT)
Status: Enrolling
Updated: 12/31/1969
University of Alabama
2079
mi
from 98109
Birmingham, AL
Click here to add this to my saved trials
Patent Foramen Ovale Closure or Medical Therapy After Stroke - RESPECT Trial
Randomized Evaluation of Recurrent Stroke Comparing PFO Closure to Established Current Standard of Care Treatment (RESPECT)
Status: Enrolling
Updated:  12/31/1969
Mayo Clinic
1114
mi
from 98109
Scottsdale, AZ
Patent Foramen Ovale Closure or Medical Therapy After Stroke - RESPECT Trial
Randomized Evaluation of Recurrent Stroke Comparing PFO Closure to Established Current Standard of Care Treatment (RESPECT)
Status: Enrolling
Updated: 12/31/1969
Mayo Clinic
1114
mi
from 98109
Scottsdale, AZ
Click here to add this to my saved trials
Patent Foramen Ovale Closure or Medical Therapy After Stroke - RESPECT Trial
Randomized Evaluation of Recurrent Stroke Comparing PFO Closure to Established Current Standard of Care Treatment (RESPECT)
Status: Enrolling
Updated:  12/31/1969
Lac & Usc Medical Center
962
mi
from 98109
Los Angeles, CA
Patent Foramen Ovale Closure or Medical Therapy After Stroke - RESPECT Trial
Randomized Evaluation of Recurrent Stroke Comparing PFO Closure to Established Current Standard of Care Treatment (RESPECT)
Status: Enrolling
Updated: 12/31/1969
Lac & Usc Medical Center
962
mi
from 98109
Los Angeles, CA
Click here to add this to my saved trials
Patent Foramen Ovale Closure or Medical Therapy After Stroke - RESPECT Trial
Randomized Evaluation of Recurrent Stroke Comparing PFO Closure to Established Current Standard of Care Treatment (RESPECT)
Status: Enrolling
Updated:  12/31/1969
UCLA
979
mi
from 98109
Los Angeles, CA
Patent Foramen Ovale Closure or Medical Therapy After Stroke - RESPECT Trial
Randomized Evaluation of Recurrent Stroke Comparing PFO Closure to Established Current Standard of Care Treatment (RESPECT)
Status: Enrolling
Updated: 12/31/1969
UCLA
979
mi
from 98109
Los Angeles, CA
Click here to add this to my saved trials
Patent Foramen Ovale Closure or Medical Therapy After Stroke - RESPECT Trial
Randomized Evaluation of Recurrent Stroke Comparing PFO Closure to Established Current Standard of Care Treatment (RESPECT)
Status: Enrolling
Updated:  12/31/1969
Summit Medical Center
677
mi
from 98109
Oakland, CA
Patent Foramen Ovale Closure or Medical Therapy After Stroke - RESPECT Trial
Randomized Evaluation of Recurrent Stroke Comparing PFO Closure to Established Current Standard of Care Treatment (RESPECT)
Status: Enrolling
Updated: 12/31/1969
Summit Medical Center
677
mi
from 98109
Oakland, CA
Click here to add this to my saved trials
Patent Foramen Ovale Closure or Medical Therapy After Stroke - RESPECT Trial
Randomized Evaluation of Recurrent Stroke Comparing PFO Closure to Established Current Standard of Care Treatment (RESPECT)
Status: Enrolling
Updated:  12/31/1969
Sharp Memorial Hospital
1060
mi
from 98109
San Diego, CA
Patent Foramen Ovale Closure or Medical Therapy After Stroke - RESPECT Trial
Randomized Evaluation of Recurrent Stroke Comparing PFO Closure to Established Current Standard of Care Treatment (RESPECT)
Status: Enrolling
Updated: 12/31/1969
Sharp Memorial Hospital
1060
mi
from 98109
San Diego, CA
Click here to add this to my saved trials
Patent Foramen Ovale Closure or Medical Therapy After Stroke - RESPECT Trial
Randomized Evaluation of Recurrent Stroke Comparing PFO Closure to Established Current Standard of Care Treatment (RESPECT)
Status: Enrolling
Updated:  12/31/1969
Kaiser Permanente
680
mi
from 98109
San Francisco, CA
Patent Foramen Ovale Closure or Medical Therapy After Stroke - RESPECT Trial
Randomized Evaluation of Recurrent Stroke Comparing PFO Closure to Established Current Standard of Care Treatment (RESPECT)
Status: Enrolling
Updated: 12/31/1969
Kaiser Permanente
680
mi
from 98109
San Francisco, CA
Click here to add this to my saved trials
Patent Foramen Ovale Closure or Medical Therapy After Stroke - RESPECT Trial
Randomized Evaluation of Recurrent Stroke Comparing PFO Closure to Established Current Standard of Care Treatment (RESPECT)
Status: Enrolling
Updated:  12/31/1969
University of Colorado
1023
mi
from 98109
Denver, CO
Patent Foramen Ovale Closure or Medical Therapy After Stroke - RESPECT Trial
Randomized Evaluation of Recurrent Stroke Comparing PFO Closure to Established Current Standard of Care Treatment (RESPECT)
Status: Enrolling
Updated: 12/31/1969
University of Colorado
1023
mi
from 98109
Denver, CO
Click here to add this to my saved trials
Patent Foramen Ovale Closure or Medical Therapy After Stroke - RESPECT Trial
Randomized Evaluation of Recurrent Stroke Comparing PFO Closure to Established Current Standard of Care Treatment (RESPECT)
Status: Enrolling
Updated:  12/31/1969
South Denver Cardiology Associates
1025
mi
from 98109
Littleton, CO
Patent Foramen Ovale Closure or Medical Therapy After Stroke - RESPECT Trial
Randomized Evaluation of Recurrent Stroke Comparing PFO Closure to Established Current Standard of Care Treatment (RESPECT)
Status: Enrolling
Updated: 12/31/1969
South Denver Cardiology Associates
1025
mi
from 98109
Littleton, CO
Click here to add this to my saved trials
Patent Foramen Ovale Closure or Medical Therapy After Stroke - RESPECT Trial
Randomized Evaluation of Recurrent Stroke Comparing PFO Closure to Established Current Standard of Care Treatment (RESPECT)
Status: Enrolling
Updated:  12/31/1969
Medical Center of the Rockies
989
mi
from 98109
Loveland, CO
Patent Foramen Ovale Closure or Medical Therapy After Stroke - RESPECT Trial
Randomized Evaluation of Recurrent Stroke Comparing PFO Closure to Established Current Standard of Care Treatment (RESPECT)
Status: Enrolling
Updated: 12/31/1969
Medical Center of the Rockies
989
mi
from 98109
Loveland, CO
Click here to add this to my saved trials
Patent Foramen Ovale Closure or Medical Therapy After Stroke - RESPECT Trial
Randomized Evaluation of Recurrent Stroke Comparing PFO Closure to Established Current Standard of Care Treatment (RESPECT)
Status: Enrolling
Updated:  12/31/1969
MedStar Washington Hospital Center
2322
mi
from 98109
Washington,
Patent Foramen Ovale Closure or Medical Therapy After Stroke - RESPECT Trial
Randomized Evaluation of Recurrent Stroke Comparing PFO Closure to Established Current Standard of Care Treatment (RESPECT)
Status: Enrolling
Updated: 12/31/1969
MedStar Washington Hospital Center
2322
mi
from 98109
Washington,
Click here to add this to my saved trials
Patent Foramen Ovale Closure or Medical Therapy After Stroke - RESPECT Trial
Randomized Evaluation of Recurrent Stroke Comparing PFO Closure to Established Current Standard of Care Treatment (RESPECT)
Status: Enrolling
Updated:  12/31/1969
George Washington University Hospital
2322
mi
from 98109
Washington,
Patent Foramen Ovale Closure or Medical Therapy After Stroke - RESPECT Trial
Randomized Evaluation of Recurrent Stroke Comparing PFO Closure to Established Current Standard of Care Treatment (RESPECT)
Status: Enrolling
Updated: 12/31/1969
George Washington University Hospital
2322
mi
from 98109
Washington,
Click here to add this to my saved trials
Patent Foramen Ovale Closure or Medical Therapy After Stroke - RESPECT Trial
Randomized Evaluation of Recurrent Stroke Comparing PFO Closure to Established Current Standard of Care Treatment (RESPECT)
Status: Enrolling
Updated:  12/31/1969
St. Vincent's Medical Center
2452
mi
from 98109
Jacksonville, FL
Patent Foramen Ovale Closure or Medical Therapy After Stroke - RESPECT Trial
Randomized Evaluation of Recurrent Stroke Comparing PFO Closure to Established Current Standard of Care Treatment (RESPECT)
Status: Enrolling
Updated: 12/31/1969
St. Vincent's Medical Center
2452
mi
from 98109
Jacksonville, FL
Click here to add this to my saved trials